Results 141 to 150 of about 282,075 (263)

MaMi study: Perceptions of pregnancy and reproductive decision‐making in women with migraine

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To characterize the influence of migraine on reproductive decision‐making in women of childbearing age and to identify potentially modifiable beliefs that could guide preconception counseling in headache clinical practice. Background Migraine is a highly prevalent neurological disorder that disproportionately affects women of ...
Nuria González‐García, Blanca Hidalgo Valverde, Ana Beatriz Gago‐Veiga, Sonia Quintas, Alicia Gonzalez‐Martinez, Jaime Rodríguez Vico, Alex Jaimes, Andrea Gómez García, Germán Latorre González, Carlos A. Calle de Miguel, Javier Díaz de Terán Velasco, David García‐Azorín, Ángel Luis Guerrero Peral, María Luz Cuadrado, Jesús Porta‐Etessam   +14 more
wiley   +1 more source

Indomethacin testing in suspected paroxysmal hemicrania and hemicrania continua: Clinical phenotypes and response patterns in a tertiary headache centre. [PDF]

Neurol Sci
Bender A, Muresan M, Joganah L, Salvat E.   +3 more
europepmc   +1 more source

The Exacerbation of Hemicrania Continua Mimics Trigeminal Neuralgia. [PDF]

Intern Med, 2019
Kato Y, Tamai Y, Hayashi T, Mizuno S, Tanahashi N, Takao M.   +5 more
europepmc   +1 more source

Distribution and target engagement of peripherally administered fremanezumab in the cerebrospinal fluid of healthy volunteers

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background Our objective was to describe the distribution of fremanezumab to the cerebrospinal fluid (CSF) in healthy volunteers, and investigate its engagement and stabilization of its target, calcitonin gene‐related peptide (CGRP). Fremanezumab is a CGRP‐targeting monoclonal antibody approved for migraine prevention.
Jacki Rorabaugh, Edward Hellriegel, Juline Bryson, Ryan Tiver, Hang Zeng, Xiaofeng Lu, Steve Barash, Giulia Ghibellini, Olga Szilagyi, Ignacio Echenique, Andrew H. Ahn, Peter J. Goadsby, Laura Rabinovich‐Guilatt   +12 more
wiley   +1 more source

Headache disorders among Indigenous communities: A scoping review undertaken with knowledge keeper guidance

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective We performed a scoping review of literature on headache etiology, classification, prevalence, and treatment in Indigenous communities in Canada, the United States, Australia, and New Zealand. Background In the United States, analysis of national prevalence indicates that Indigenous Americans lead all other racial/ethnic groups in ...
Maia Kelly, Candice M. Todd, Ojistoh Kahnawahere Horn, Emily Simmonds, Diane Longboat, Cynthia White, Suvendrini Lena   +6 more
wiley   +1 more source

Hemicrania continua with rhinosinusitis: a case report. [PDF]

Korean J Fam Med
Kim DH, Lee Y.
europepmc   +1 more source

A case of remitting hemicrania continua with seasonal variation and clustering: a diagnostic confusion with cluster headache. [PDF]

BMJ Case Rep, 2019
Prakash S, Rawat KS.
europepmc   +1 more source

Opioid use, disability, and patient‐reported cognitive impairment in migraine: Multi‐country results from the Chronic Migraine Epidemiology and Outcomes—International Study

Headache: The Journal of Head and Face Pain, EarlyView.
Plain Language Summary Opioids are widely used to treat migraine despite being contrary to clinical guidelines. In the Chronic Migraine Epidemiology and Outcomes–International (CaMEO‐I) Study, a large, international survey of people with migraine, opioid users were more likely than nonusers to experience moderate or severe migraine‐related disability ...
Elizabeth Leroux, Dawn C. Buse, Michel Lanteri‐Minet, Fumihiko Sakai, Manjit Matharu, Zaza Katsarava, Kristina M. Fanning, Karen Carr, Nicole Naccara, Janette Contreras‐De Lama, Richard B. Lipton   +10 more
wiley   +1 more source

Third Occipital Nerve Block and Cooled Radiofrequency Ablation for Managing Hemicrania Continua: A Case Report. [PDF]

Cureus
Barbari C, Patel D, Cohen J.
europepmc   +1 more source

Pregnancy outcomes following exposure to galcanezumab: Analysis of cases from the galcanezumab clinical trials and postmarketing database

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective This study was conducted to describe pregnancy outcomes reported following maternal or paternal exposure to galcanezumab in clinical trials and postmarketing surveillance. Background Galcanezumab is a calcitonin gene‐related peptide‐inhibiting monoclonal antibody indicated for the preventive treatment of migraine.
Irene Boz, Jan Lewis Brandes, Christopher Robinson, Maria Fernanda Scantamburlo Fernandes, Sarah Lipsius, LaRonda Morford, Enemona Emmanuel Adaji, Anaclara Prada Jardim, Holland C. Detke   +8 more
wiley   +1 more source